These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9503043)

  • 1. Background and rationale behind the SU.VI.MAX Study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. SUpplementation en VItamines et Minéraux AntioXydants Study.
    Hercberg S; Galan P; Preziosi P; Roussel AM; Arnaud J; Richard MJ; Malvy D; Paul-Dauphin A; Briançon S; Favier A
    Int J Vitam Nutr Res; 1998; 68(1):3-20. PubMed ID: 9503043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two years' supplementation with natural antioxidants on vitamin and trace element status biomarkers: preliminary data of the SU.VI.MAX study.
    Malvy DJ; Favier A; Faure H; Preziosi P; Galan P; Arnaud J; Roussel AM; Briançon S; Hercberg S
    Cancer Detect Prev; 2001; 25(5):479-85. PubMed ID: 11718454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The bank of biological material in the SU.VI.MAX study].
    Galan P; Favier A; Preziosi P; Bertrais S; Arnault N; Hercberg S
    Rev Epidemiol Sante Publique; 2003 Feb; 51(1 Pt 2):147-50. PubMed ID: 12684572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antioxidant micronutrients and chronic degenerative pathology: the role of complementary nutritional doses].
    Hercberg S
    Bull Mem Acad R Med Belg; 1997; 152(10-11):379-85; discussion 385-7. PubMed ID: 9627441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamines et Minéraux AntioXydants.
    Hercberg S; Preziosi P; Briançon S; Galan P; Triol I; Malvy D; Roussel AM; Favier A
    Control Clin Trials; 1998 Aug; 19(4):336-51. PubMed ID: 9683310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary fibre intake and clinical indices in the French Supplementation en Vitamines et Minéraux AntioXydants (SU.VI.MAX) adult cohort.
    Lairon D; Bertrais S; Vincent S; Arnault N; Galan P; Boutron MC; Hercberg S;
    Proc Nutr Soc; 2003 Feb; 62(1):11-5. PubMed ID: 12740051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants.
    Hercberg S; Preziosi P; Galan P; Faure H; Arnaud J; Duport N; Malvy D; Roussel AM; Briançon S; Favier A
    Food Chem Toxicol; 1999; 37(9-10):925-30. PubMed ID: 10541446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing blood concentration of retinol, alpha-tocopherol, vitamin C, and beta-carotene in the French participants of the SU.VI.MAX trial.
    Faure H; Preziosi P; Roussel AM; Bertrais S; Galan P; Hercberg S; Favier A
    Eur J Clin Nutr; 2006 Jun; 60(6):706-17. PubMed ID: 16391586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antioxidant supplements and risk of hypertension in the SU.VI.MAX trial: relationship to plasma antioxidants].
    Czernichow S; Bertrais S; Blacher J; Galan P; Briançon S; Favier A; Safar M; Hercberg S
    Arch Mal Coeur Vaiss; 2006; 99(7-8):665-8. PubMed ID: 17061440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations.
    Czernichow S; Couthouis A; Bertrais S; Vergnaud AC; Dauchet L; Galan P; Hercberg S
    Am J Clin Nutr; 2006 Aug; 84(2):395-9. PubMed ID: 16895889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals.
    Hercberg S; Galan P; Preziosi P; Bertrais S; Mennen L; Malvy D; Roussel AM; Favier A; Briançon S
    Arch Intern Med; 2004 Nov; 164(21):2335-42. PubMed ID: 15557412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there a role for antioxidant vitamins in the prevention of cardiovascular diseases? An update on epidemiological and clinical trials data.
    Lonn EM; Yusuf S
    Can J Cardiol; 1997 Oct; 13(10):957-65. PubMed ID: 9374952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood lipid and lipoprotein levels: relationships with educational level and region of residence in the French SU.VI.MAX study.
    Bruckert E; Czernichow S; Bertrais S; Paillard F; Tichet J; Galan P; Castetbon K; Hercberg S
    Prev Med; 2005 Jun; 40(6):803-11. PubMed ID: 15850882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SU.VI.MAX trial on antioxidants.
    Hercberg S; Galan P; Preziosi P; Malvy M; Briançon S; Ait HM; Rahim B; Favier A
    IARC Sci Publ; 2002; 156():451-5. PubMed ID: 12484233
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of 6 month supplementation with different combinations of an association of antioxidant nutrients on biochemical parameters and markers of the antioxidant defence system in the elderly. The Geriatrie/Min.Vit.Aox Network.
    Monget AL; Richard MJ; Cournot MP; Arnaud J; Galan P; Preziosi P; Herbeth B; Favier A; Hercberg S
    Eur J Clin Nutr; 1996 Jul; 50(7):443-9. PubMed ID: 8862480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventional studies concerning the role of antioxidant vitamins in cardiovascular diseases: a review.
    Czernichow S; Hercberg S
    J Nutr Health Aging; 2001; 5(3):188-95. PubMed ID: 11458291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The SUVIMAX (France) study: the role of antioxidants in the prevention of cancer and cardiovascular disorders].
    Vázquez Martínez C; Galán P; Preziosi P; Ribas L; Serra LL; Hercberg S
    Rev Esp Salud Publica; 1998; 72(3):173-83. PubMed ID: 9810825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. French adults' cognitive performance after daily supplementation with antioxidant vitamins and minerals at nutritional doses: a post hoc analysis of the Supplementation in Vitamins and Mineral Antioxidants (SU.VI.MAX) trial.
    Kesse-Guyot E; Fezeu L; Jeandel C; Ferry M; Andreeva V; Amieva H; Hercberg S; Galan P
    Am J Clin Nutr; 2011 Sep; 94(3):892-9. PubMed ID: 21775560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Healthy Aging 5 Years After a Period of Daily Supplementation With Antioxidant Nutrients: A Post Hoc Analysis of the French Randomized Trial SU.VI.MAX.
    Assmann KE; Andreeva VA; Jeandel C; Hercberg S; Galan P; Kesse-Guyot E
    Am J Epidemiol; 2015 Oct; 182(8):694-704. PubMed ID: 26374140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term antioxidant supplementation has no effect on health-related quality of life: the randomized, double-blind, placebo-controlled, primary prevention SU.VI.MAX trial.
    Briançon S; Boini S; Bertrais S; Guillemin F; Galan P; Hercberg S
    Int J Epidemiol; 2011 Dec; 40(6):1605-16. PubMed ID: 22158670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.